Search research articles
Contact Us
Filters
Showing results (71-80 of 100) with videos related to
Page
of 10
Sort By:
Asia-Pacific Journal of Clinical Oncology
|
May 7, 2014
Systemic treatment of HER2-positive metastatic breast cancer: a systematic review
Nicholas Wilcken, Nicholas Zdenkowski, Michelle White, et al.
Journal of Bone Oncology
|
February 25, 2016
Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial
Anna J Lomax, Saw Yee Yap, Karen White, et al.
BJU International
|
January 8, 2020
Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit - the 'Fry-Turnbull' effect
Catherine E Lovegrove, Omar Musbahi, Nithesh Ranasinha, et al.
Clinical Breast Cancer
|
May 14, 2004
Use of trastuzumab beyond disease progression: observations from a retrospective review of case histories
Karen A Gelmon, John Mackey, Shailendra Verma, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
September 19, 2022
Adaptive immune responses in patients requiring revision after total knee arthroplasty
Daniel Jenkins, Swati Phalke, Richard Bell, et al.
Plant Physiology and Biochemistry : PPB
|
November 16, 2025
Large scale genome-wide association analysis identified QTLs associated with aluminum tolerance in chickpea
Yong Jia, Sharon Westcott, Karthika Pradeep, et al.
The Lancet. Oncology
|
July 19, 2014
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
Robert Coleman, David Cameron, David Dodwell, et al.
Breast Cancer Research and Treatment
|
December 29, 2015
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience
Otto Metzger-Filho, Evandro de Azambuja, Marion Procter, et al.
Blood
|
March 15, 2003
Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age
Linda Mileshkin, James J Biagi, Paul Mitchell, et al.
Science Immunology
|
June 26, 2026
Langerhans cell control of early-life dermal lymphatic development shapes adult immunity
Ji Hyun Sim, Richard Bell, Yurii Chinenov, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 100) with videos related to
Sort By:
Page
of 10
Asia-Pacific Journal of Clinical Oncology
|
May 7, 2014
Systemic treatment of HER2-positive metastatic breast cancer: a systematic review
Nicholas Wilcken, Nicholas Zdenkowski, Michelle White, et al.
Journal of Bone Oncology
|
February 25, 2016
Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial
Anna J Lomax, Saw Yee Yap, Karen White, et al.
BJU International
|
January 8, 2020
Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit - the 'Fry-Turnbull' effect
Catherine E Lovegrove, Omar Musbahi, Nithesh Ranasinha, et al.
Clinical Breast Cancer
|
May 14, 2004
Use of trastuzumab beyond disease progression: observations from a retrospective review of case histories
Karen A Gelmon, John Mackey, Shailendra Verma, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
September 19, 2022
Adaptive immune responses in patients requiring revision after total knee arthroplasty
Daniel Jenkins, Swati Phalke, Richard Bell, et al.
Plant Physiology and Biochemistry : PPB
|
November 16, 2025
Large scale genome-wide association analysis identified QTLs associated with aluminum tolerance in chickpea
Yong Jia, Sharon Westcott, Karthika Pradeep, et al.
The Lancet. Oncology
|
July 19, 2014
Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial
Robert Coleman, David Cameron, David Dodwell, et al.
Breast Cancer Research and Treatment
|
December 29, 2015
Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience
Otto Metzger-Filho, Evandro de Azambuja, Marion Procter, et al.
Blood
|
March 15, 2003
Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age
Linda Mileshkin, James J Biagi, Paul Mitchell, et al.
Science Immunology
|
June 26, 2026
Langerhans cell control of early-life dermal lymphatic development shapes adult immunity
Ji Hyun Sim, Richard Bell, Yurii Chinenov, et al.
Page
of 10